Steve Self

发表

Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Raphael Gottardo, Hongmei Gao, Bette T. Korber, 2013, Journal of Virology.

Modeling a Marker of Disease Progression and Onset of Disease

Yudi Pawitan, Y. Pawitan, S. Self, 1992 .

A transdimensional Bayesian model for pattern recognition in DNA sequences.

Jon Wakefield, J. Wakefield, S. Self, 2008, Biostatistics.

Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection

Xuesong Yu, L. Stamatatos, S. Self, 2008, Journal of Virology.

Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

Raphael Gottardo, S. Gnanakaran, Hongmei Gao, 2013, PloS one.

Modeling Disease Marker Processes in AIDS

Yudi Pawitan, Y. Pawitan, S. Self, 1993 .

Capturing viral diversity for in-vitro test reagents and HIV vaccine immunogen design

Bette Korber, Christian Brander, B. Korber, 2007, Current opinion in HIV and AIDS.

Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection

Mario Roederer, Bette Korber, Guido Ferrari, 2011, PLoS pathogens.

Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.

Marie-Claude Boily, Kamal Desai, S. Self, 2008, The Lancet. Infectious diseases.

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Feng Gao, Hui Li, Guido Ferrari, 2012, The Journal of clinical investigation.